As of 30 November 2025, Cloudpharm and its partners have successfully completed the Horizon Europe–funded project ENVIROMED. The project represents a key contribution to the EU Green Deal, having developed innovative technologies that enable greener and more efficient pharmaceutical production while reducing environmental impact and maintaining high standards of quality and safety.
Throughout its implementation, ENVIROMED was supported by six plenary meetings that ensured close collaboration and effective coordination among partners, alongside active dissemination through international exhibitions such as CPHI. The project’s scientific outcomes have further been consolidated through the preparation of peer-reviewed publications, demonstrating the potential for more sustainable and environmentally responsible pharmaceutical manufacturing.